Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2011 | 3 |
2012 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.
Breast Cancer Res. 2012 May 2;14(3):R70. doi: 10.1186/bcr3179.
Breast Cancer Res. 2012.
PMID: 22551440
Free PMC article.
Clinical Trial.
p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines.
Anaganti S, Fernández-Cuesta L, Langerød A, Hainaut P, Olivier M.
Anaganti S, et al.
Cancer Lett. 2011 Jan 28;300(2):215-24. doi: 10.1016/j.canlet.2010.10.008. Epub 2010 Nov 10.
Cancer Lett. 2011.
PMID: 21071137
Item in Clipboard
p53 status influences response to tamoxifen but not to fulvestrant in breast cancer cell lines.
Fernandez-Cuesta L, Anaganti S, Hainaut P, Olivier M.
Fernandez-Cuesta L, et al.
Int J Cancer. 2011 Apr 15;128(8):1813-21. doi: 10.1002/ijc.25512.
Int J Cancer. 2011.
PMID: 20549698
Free article.
Item in Clipboard
Estrogen levels act as a rheostat on p53 levels and modulate p53-dependent responses in breast cancer cell lines.
Fernández-Cuesta L, Anaganti S, Hainaut P, Olivier M.
Fernández-Cuesta L, et al.
Breast Cancer Res Treat. 2011 Jan;125(1):35-42. doi: 10.1007/s10549-010-0819-x. Epub 2010 Mar 11.
Breast Cancer Res Treat. 2011.
PMID: 20221692
Item in Clipboard
Cite
Cite